Nisa Investment Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Buy
4,077
+19
+0.5% +$492 ﹤0.01% 1420
2025
Q4
$103K Hold
4,058
﹤0.01% 1426
2025
Q3
$65.4K Buy
4,058
+92
+2% +$1.49K ﹤0.01% 1555
2025
Q2
$63.5K Sell
3,966
-60
-1% -$907 ﹤0.01% 1532
2025
Q1
$68.8K Buy
4,026
+17
+0.4% +$356 ﹤0.01% 1494
2024
Q4
$99.3K Buy
4,009
+127
+3% +$3.6K ﹤0.01% 1475
2024
Q3
$111K Buy
3,882
+44
+1% +$1.3K ﹤0.01% 1419
2024
Q2
$101K Buy
3,838
+41
+1% +$1.17K ﹤0.01% 1475
2024
Q1
$123K Buy
3,797
+38
+1% +$1.39K ﹤0.01% 1414
2023
Q4
$158K Sell
3,759
-100
-3% -$3.68K ﹤0.01% 1326
2023
Q3
$148K Hold
3,859
﹤0.01% 1390
2023
Q2
$73.2K Buy
3,859
+270
+8% +$5.04K ﹤0.01% 1614
2023
Q1
$56K Sell
3,589
-2,250
-39% -$39K ﹤0.01% 1683
2022
Q4
$104K Buy
5,839
+39
+0.7% +$491 ﹤0.01% 1544
2022
Q3
$59K Buy
5,800
+1,000
+21% +$4.89K ﹤0.01% 1684
2022
Q2
$19K Buy
4,800
+4,400
+1,100% +$19K ﹤0.01% 2058
2022
Q1
$2K Sell
400
-3,620
-90% -$22.5K ﹤0.01% 2342
2021
Q4
$28K Sell
4,020
-2,880
-42% -$23.8K ﹤0.01% 1867
2021
Q3
$60 Buy
6,900
+6,500
+1,625% +$58.6K ﹤0.01% 1892
2021
Q2
$4 Hold
400
﹤0.01% 2284
2021
Q1
$6 Sell
400
-1,300
-76% -$34.3K ﹤0.01% 2250
2020
Q4
$79K Buy
+1,700
New +$78.6K ﹤0.01% 1833

Other funds holding IMVT